carbidopa has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, H; Martinez, J; Norcliffe-Kaufmann, L; Palma, JA | 1 |
| Axelrod, F; Kaufmann, H; Martinez, J; Norcliffe-Kaufmann, L | 1 |
2 trial(s) available for carbidopa and Dominant Hereditary Sensory Neuropathy, Type III
| Article | Year |
|---|---|
Carbidopa for Afferent Baroreflex Failure in Familial Dysautonomia: A Double-Blind Randomized Crossover Clinical Trial.
Topics: Adult; Afferent Pathways; Aromatic Amino Acid Decarboxylase Inhibitors; Baroreflex; Blood Pressure; Carbidopa; Catecholamines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Dysautonomia, Familial; Female; Humans; Hypertension; Male; Treatment Outcome | 2020 |
Hyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa.
Topics: Adolescent; Adult; Antiemetics; Carbidopa; Child; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Dysautonomia, Familial; Female; Humans; Male; Nausea; Vomiting; Young Adult | 2013 |